Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes.
Nyma Z, Kitaoka K, Yano Y, Kanegae H, Bayaraa N, Kishi S, Nagasu H, Nakano T, Wada J, Maruyama S, Nakagawa N, Tamura K, Yokoo T, Yanagita M, Narita I, Yamagata K, Wada T, Tsuruya K, Nakashima N, Isaka Y, Nangaku M, Kashihara N, Okada H; J-CKD-DB study collaborative. Nyma Z, et al. Sci Rep. 2024 May 20;14(1):11481. doi: 10.1038/s41598-024-62152-6. Sci Rep. 2024. PMID: 38769367 Free PMC article.
A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation.
Nakamura Y, Urakami T, Ishimaru K, Vuong Tran NQ, Shimizu T, Sinko W, Takahashi T, Marappan S, Narayanan K, Poddutoori R, Terada Y, Nakao A. Nakamura Y, et al. Among authors: terada y. J Allergy Clin Immunol Glob. 2024 Apr 3;3(3):100249. doi: 10.1016/j.jacig.2024.100249. eCollection 2024 Aug. J Allergy Clin Immunol Glob. 2024. PMID: 38764489 Free PMC article.
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65.
Li J, Hamamura K, Yoshida Y, Kawano S, Uchinomiya S, Xie J, Scuteri D, Fukuoka K, Zaitsu O, Tsurusaki F, Terada Y, Tsukamoto R, Nishi T, Fukuda T, Oyama K, Bagetta G, Ojida A, Shimizu K, Ohdo S, Matsunaga N. Li J, et al. Among authors: terada y. Biochem Biophys Res Commun. 2024 May 14;720:150077. doi: 10.1016/j.bbrc.2024.150077. Online ahead of print. Biochem Biophys Res Commun. 2024. PMID: 38759303 Free article.
Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
Kanaoka T, Wakui H, Yano Y, Nagasu H, Kanegae H, Nangaku M, Hirakawa Y, Nakagawa N, Wada J, Tsuruya K, Nakano T, Maruyama S, Wada T, Konishi M, Nagahiro T, Yamagata K, Narita I, Yanagita M, Terada Y, Araki S, Emoto M, Okada H, Isaka Y, Suzuki Y, Yokoo T, Kataoka H, Kanda E, Kashihara N, Tamura K; J‐CKD‐DB investigators. Kanaoka T, et al. Among authors: terada y. Diabetes Obes Metab. 2024 May 8. doi: 10.1111/dom.15611. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38719436
Intravital Two-Photon Microscopy of the Transplanted Mouse Lung.
Bai YZ, Terada Y, Mineura K, Yokoyama Y, Nava RG, Krupnick AS, Gelman AE, Miller MJ, Kreisel D, Li W. Bai YZ, et al. Among authors: terada y. J Vis Exp. 2024 Apr 19;(206). doi: 10.3791/66566. J Vis Exp. 2024. PMID: 38709031
A case of hereditary breast and ovarian cancer syndrome of initially presented as cancer of unknown primary with lymph node metastases unveiled by genetic analysis.
Yamada J, Fukuda K, Sugawara T, Makino K, Shimazu K, Yoshida T, Taguchi D, Shinozaki H, Terada Y, Nanjo H, Shibata H. Yamada J, et al. Among authors: terada y. Int Cancer Conf J. 2024 Feb 9;13(2):139-143. doi: 10.1007/s13691-023-00652-4. eCollection 2024 Apr. Int Cancer Conf J. 2024. PMID: 38524651 Free PMC article.
1,424 results